Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.



Date Headline/Title
09 December 2021Report on Annual General Meeting proceedings
03 December 2021Renewal of Cautionary Announcement – API Business
30 November 2021Aspen confirms Non-binding Term Sheet on manufacture and sale of an Aspen branded COVID-19 vaccine throughout Africa
29 November 2021Cautionary announcement – Discussions to conclude COVID-19 Licensing Agreement
23 November 2021Broad-Based Black Economic Empowerment Certificate
09 November 2021Appointment of Dr Yvonne Muthien as independent Non-executive director
28 October 2021Confirmation of release of Integrated Report and further notice of AGM to be held on 9 December 2021
27 October 2021Dealing in securities by Directors, Company Secretary and Prescribed Officers of the company
27 October 2021Vesting and delayed delivery of securities for Directors, Company Secretary and Prescribed Officers of the Company
22 October 2021Divestment of a portfolio of six South African products to Acino
21 October 2021Renewal of Cautionary Announcement – API Business
04 October 2021No Change Statement and Notice of Annual General Meeting – 9 December 2021
09 September 2021Cautionary Announcement – API Business
03 September 2021Changes to the board and its committees – Retirement of Sindi Zilwa
01 September 2021Aspen final results June 2021
25 August 2021Aspen’s results for the year ended 30 June 2021 and results presentation
05 August 2021Changes to the Board – Appointment of Sean Capazorio as Executive Director and Group Chief Financial Officer
26 July 2021Aspen confirms release of COVID-19 vaccines to Johnson & Johnson for supply to South Africa
01 July 2021Final Completion of the Divestment of the European Thrombosis Business to Mylan/Viatris
30 June 2021Aspen secures new financing package
24 June 2021Illustrative historic revenue information
14 June 2021Aspen Statement on Manufacture and Supply of COVID-19 Vaccines
31 May 2021Aspen Pledges its Support of Equitable Vaccine Access in Africa
11 March 2021Aspen interim results December 2020
04 March 2021Amended release date of Aspen’s Interim Results for the six months ended 31 December 2020 and Results Presentation
04 March 2021Release date of Aspen’s Interim Results for the six months ended 31 December 2020 and Results Presentation
01 March 2021Aspen’s Interim Results for the six months ended 31 December 2020 and Results presentation
23 February 2021Trading Statement
10 February 2021Gus Attridge to step down at end of 2021
10 February 2021European Commission’s acceptance of Aspen’s commitments to address the preliminary assessment regarding pricing
Powered by ProfileData